Prognostic value of positive lymph nodes in rectal cancer
- 1 June 1992
- journal article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 35 (6) , 579-581
- https://doi.org/10.1007/bf02050539
Abstract
Abdominal "curative" resections for rectal cancer in 109 patients with positive lymph nodes were prospectively studied. The best subdivision of patients for predicting outcome was into 1-3 and greater than 3 positive lymph node groups. Comparison with patients with greater than 3 positive lymph nodes demonstrated that patients with 1-3 positive nodes had less local (35.0 percent vs. 13.0 percent; P = 0.007) and less distant recurrence (45.0 percent vs. 26.0 percent; P = 0.04) and had much better crude five-year survival (58.2 percent vs. 17.0 percent; P less than 0.0001). For predicting postsurgical outcome in patients with positive lymph nodes, the results justify subdividing patients into the following two prognostic subgroups: 1) those with 1-3 involved lymph nodes and 2) those with metastatic tumor in four or more lymph nodes.Keywords
This publication has 4 references indexed in Scilit:
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- The Prognostic Value of the Modifications of the Dukesʼ C Class of Colorectal CancerAnnals of Surgery, 1986
- Prognostic factors in carcinoma of the colon and rectumThe American Journal of Surgery, 1968
- The Surgical Pathology of Rectal CancerJournal of Clinical Pathology, 1949